Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR)

OBJECTIVES: Biologic treatments have revolutionized the management of PsA by significantly improving clinical manifestations and preventing structural damage. Both result in better quality of life and improved physical functioning. Since the introduction of the first TNF inhibitor (TNFi) in the earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishchenko, Alla, Joly, Johan, Neerinckx, Barbara, Lories, Rik, de Vlam, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651220/
https://www.ncbi.nlm.nih.gov/pubmed/34888434
http://dx.doi.org/10.1093/rap/rkab085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651220/
https://www.ncbi.nlm.nih.gov/pubmed/34888434
http://dx.doi.org/10.1093/rap/rkab085

Ejemplares similares